Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?

BACKGROUND: Histological transformation of oncogene-driven lung adenocarcinoma to small cell lung cancer (SCLC) following treatment with tyrosine kinase inhibitors (TKIs) is a well-described phenomenon. Whether a similar transformation may drive acquired resistance to immune checkpoint inhibitors (I...

Descripción completa

Detalles Bibliográficos
Autores principales: Sehgal, Kartik, Varkaris, Andreas, Viray, Hollis, VanderLaan, Paul A, Rangachari, Deepa, Costa, Daniel B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312456/
https://www.ncbi.nlm.nih.gov/pubmed/32581048
http://dx.doi.org/10.1136/jitc-2020-000697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312456/
https://www.ncbi.nlm.nih.gov/pubmed/32581048
http://dx.doi.org/10.1136/jitc-2020-000697

Ejemplares similares